UPLOAD Filing
TriSalus Life Sciences, Inc.
Date: April 30, 2025 · CIK: 0001826667 · Accession: 0000000000-25-004562
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-286779
Letter
Re: TriSalus Life Sciences, Inc. Registration Statement on Form S-3 Filed April 25, 2025 File No. 333-286779 Dear Mary Szela:
April 30, 2025
Mary Szela Chief Executive Officer TriSalus Life Sciences, Inc. 6272 W. 91st Ave. Westminster, CO 80031
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Margaret Sawicki at 202-551-7153 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Industrial
Applications and
Services
cc: Matthew Browne, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> April 30, 2025 Mary Szela Chief Executive Officer TriSalus Life Sciences, Inc. 6272 W. 91st Ave. Westminster, CO 80031 Re: TriSalus Life Sciences, Inc. Registration Statement on Form S-3 Filed April 25, 2025 File No. 333-286779 Dear Mary Szela: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Margaret Sawicki at 202-551-7153 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Matthew Browne, Esq. </TEXT> </DOCUMENT>